peoplePerson
Nathan Cherny
Created the ESMO Magnitude of Clinical Benefit Scale, the standard tool for grading how much a cancer drug really helps.
Nathan Cherny led the development of the ESMO-MCBS, which grades trial results by magnitude of benefit and is used by health systems worldwide; he is a palliative medicine physician in Jerusalem.
Role
Director, Cancer Pain and Palliative Medicine, Shaare Zedek Medical Center; Chair, ESMO-MCBS Working Group
Institution
Specialisms
Palliative medicineValue assessment of cancer drugsEthics
Profiles
Pages like this
not linked directly; found by shared links- IdeaLiving, machine-readable guidelines pushed to the point of care in every country
Shares Standard of care, European Society for Medical Oncology (ESMO).
- Key paperPrasad: most surrogate endpoints in cancer trials correlate poorly with survival
Shares Win-ratio endpoints that weigh survival, toxicity and quality of life together, Power trials to detect a benefit patients would value, not the smallest detectable one.
- BottleneckPain relief and palliative care are unavailable to most
Shares Treat wasting like sepsis: a trigger, a bundle, an audit, Shaare Zedek Medical Center, European Society for Medical Oncology (ESMO).